Home > PE Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of TORRENT PHARMACEUTICALS is 77.61.

Share Price ₹4,903.4Jul 10,2026
Market Cap ₹165,929.4 Cr
Earnings-TTM₹2,138.0 CrTTM-Consolidated Results
Price/Earnings77.61xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of TORRENT PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹165,929.4 Cr] as on Jul 10,2026

(/) Earnings [ ₹2,138.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 77.61x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay 77.61 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of TORRENT PHARMACEUTICALS


PE Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/e ratio is 77.61x.

- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 49.74x.

- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 53.15x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 66.03x.

- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 30.45x.


How does TORRENT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
TORRENT PHARMACEUTICALS 2,138.0077.61165,929.4
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5040.15464,331.0
DIVIS LABORATORIES LTD2,568.0070.66181,466.0
CIPLA LTD3,869.7930.03116,229.0
DR REDDYS LABORATORIES LTD4,144.2025.09103,959.0
MANKIND PHARMA LTD1,926.4154.13104,275.0
LUPIN LTD5,355.4721.31114,128.0
ZYDUS LIFESCIENCES LTD5,026.4022.83114,763.0
AUROBINDO PHARMA LTD3,501.4525.7190,026.5
LAURUS LABS LTD889.8593.3983,103.9
BIOCON LTD368.80184.9168,194.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TORRENT PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 21.31x
Max industry PE 184.91x
Median industry PE 40.15x
Average industry PE 58.71x



You may also like the below Video Courses